Neuromodulation Market to Grow at a CAGR of 10.3% to reach US$ 16,333.98 Million from 2020 to 2027
Medical Device Neuromodulation Market Forecast to ...

Neuromodulation Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (External (Non-Invasive) Neuromodulation, and Internal Neuromodulation); Application (Chronic Pain Management, Failed Back Syndrome, Epilepsy, Tremor, Incontinence, Depression, Dystonia, Gastroparesis, Parkinson’s Disease, Obsessive-Compulsive Disorder, and Migraine); End User (Hospitals, Clinics, and Home Healthcare), and Geography

Publication Month: Oct 2020 | Report Code: TIPHE100001415 | No. of Pages: 195 | Category: Medical Device | Status: Published
Covid

The Neuromodulationmarket was valued at US$ 7,613.45 million in 2019 and is projected to reach US$ 16,333.98 million by 2027; it is expected to grow at a CAGR of 10.3%during 2020–2027.

 

Neurological disorders such as cerebrovascular diseases, Alzheimer’s disease, and Parkinson's disease can be treated with the help of neuromodulation that is performed by using various devices or infusing drugs. Devices used in neuromodulation involve the application of electrodes to the spinal cord, brain, or peripheral nerves.

 

Lucrative Regions in Neuromodulation Market

Lucrative Regions in Neuromodulation Market

Get more information on this report :

 

Market Insights

Increasing Incidence of Neurological Disorders Drives Market Growth

Depression is the most common neurological disorder among all age groups. In the developing regions, most people suffer from depression owing to various socioeconomic factors such as financial stress and poverty. Other neurological disorders such as dystonia, Parkinson’s disease, and obsessive-compulsive disorder are usually observed in aging population. According to a study ‘Incidence and Prevalence of Major Neurologic Disorders,’ published in January 2018, ~36% of elderly have moderate or severe memory impairment in the US. Each year nearly 1.2 million adults are diagnosed with brain disorders, of which 51.3% is due to stroke and 21% due to Alzheimer’s disease. In addition, nearly 135 million people are diagnosed with Parkinson’s disease, traumatic brain injury, and epilepsy each year. Moreover, ~500,000 cases of brain tumor, multiple sclerosis, and amyotrophic lateral sclerosis are reported annually. Therefore, the growing prevalence of neurological disorders is consequently propelling the demand for neuromodulators as these help in relieving neurological symptoms. Furthermore, the rising demand for neurostimulation devices to treat chronic pain.

 

Products Insights

In terms of technology, the external (non-invasive) neuromodulation segment held a greater share of the neuromodulation market in 2019. The same segment is expected to continue its dominance  and register a higher CAGR in the market during the forecast period.

 

Neuromodulation Market, by Technology – 2019 and 2027

Neuromodulation Market, by Technology – 2019 and 2027

Get more information on this report :


Application Insights

Based on application, the global neuromodulation market is segmented into chronic pain management, failed back syndrome, epilepsy, tremor, incontinence, depression, dystonia, gastroparesis, Parkinsons’s disease, obsessive-compulsive disorder, and migraine. The chronic pain management segment held the largest share of the market in 2019, and it is expected to register the highest CAGR during the forecast period.

Chronic pain management helps relieve pain with the use of drugs, therapies, and lifestyle changes. Electrical stimulation devices play a major role in pain management as they are primarily developed for relieving several types of chronic and acute pain.Growing geriatric population, increasing chronic condition prevalence, and sedentary lifestyle are a few of the risk factors that may cause chronic pain. For instance, according to a study published by Arthritis Foundation in 2019, aging population is responsible for the growing prevalence of all types of diseases across the world. The same study stated that1 in 3 people in the US suffers from arthritis each year. Therefore, the rising prevalence of chronic pain is expected to drive the growth of the segment during the forecast period.

The incorporation of advanced technologies in electrical stimulation devices enables additional benefits for pain management. For instance, in January 2019, Abbott announced test results of BurstDR stimulation developed for the treatment of chronic pain. The results show thatthe product reduces pain by around 60–70%.

 

Strategic Insights

Players operating in the neuromodulation market adopt collaboration and partnership strategies to meet demands of end users through the introduction of technologically advanced offerings, and these strategies  significantly support the growth of the market. 

 

By Technology

  • External (Non-Invasive) Neuromodulation
    • Respiratory Electrical Stimulation
    • Transcutaneous Electrical Nerve Stimulation
    • Transcranial Magnetic Stimulation
  • Internal Neuromodulation
    • Deep Brain Stimulation
    • Sacral Nerve Stimulation
    • Gastric Electrical Stimulation
    • Spinal Cord Stimulation
    • Vagus Nerve Stimulation

By Application

  • Chronic Pain Management
  • Failed Back Syndrome
  • Epilepsy
  • Tremor
  • Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Obsessive-Compulsive Disorder
  • Migraine
By End User
  • Hospitals
  • Clinics
  • Home Healthcare

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Russia
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

  • Abbott
  • Boston Scientific Corporation
  • Medtronic
  • NeuroPace, Inc.
  • NeuroSigma, Inc.
  • NEVRO CORP.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc
  • Integer Holdings Corporation
  • Magstim 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1       Neuromodulation Market – By Technology

1.3.2       Neuromodulation Market – By Application

1.3.3       Neuromodulation Market – By End User

1.3.4       Global Neuromodulation Market – By Geography

2.             Neuromodulation Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Neuromodulation– Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1       North America – PEST Analysis

4.2.2       Europe – PEST Analysis

4.2.3       Asia Pacific – PEST Analysis

4.2.4       Middle East and Africa (MEA) – PEST Analysis

4.2.5       South and Central America (SCAM) – PEST Analysis

4.3       Expert Opinions

5.             Neuromodulation Market – Key Market Dynamics

5.1       Market Drivers

5.1.1       Increasing Incidence of Neurological Disorders

5.1.2       Growing Developments in Neuromodulation Technology

5.2       Market Restraints

5.2.1       High Cost of Neuromodulation Devices

5.3       Market Opportunities

5.3.1       Rising Demand for Neurostimulation Devices to Treat Chronic Pain

5.4       Future Trends

5.4.1       Technological Advancements

5.5       Impact Analysis

6.             Neuromodulation Market– Global Analysis

6.1       Global Neuromodulation Market Revenue Forecast and Analysis

6.2       Global Neuromodulation Market, By Geography - Forecast and Analysis

6.3       Market Positioning of Key Players

7.             Neuromodulation Market Analysis – By Technology

7.1       Overview

7.2       Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

7.3       External Neuromodulation

7.3.1       Overview

7.3.2       External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.3       Respiratory Electrical Stimulation (RES)

7.3.3.1      Overview

7.3.3.2      Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.4       Transcutaneous Electrical Nerve Stimulation (TENS)

7.3.4.1      Overview

7.3.4.2      Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.3.5       Transcranial Magnetic Stimulation (TMS)

7.3.5.1      Overview

7.3.5.2      Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4       Internal Neuromodulation

7.4.1       Overview

7.4.2       Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.3       Deep Brain Stimulation (DBS)

7.4.3.1      Overview

7.4.3.2      Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.4       Sacral Nerve Stimulation (DBS)

7.4.4.1      Overview

7.4.4.2      Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.5       Gastric Electric Stimulation (GES)

7.4.5.1      Overview

7.4.5.2      Gastric Electric Stimulation (GES): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.6       Spinal Cord Stimulation (SCS)

7.4.6.1      Overview

7.4.6.2      Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

7.4.7       Vagus Nerve Stimulation (VNS)

7.4.7.1      Overview

7.4.7.2      Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.             Neuromodulation Market Analysis – By Application

8.1       Overview

8.2       Neuromodulation Market Share, by Application, 2019 and 2027 (%)

8.3       Chronic Pain Management

8.3.1       Overview

8.3.2       Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.4       Failed Back Syndrome

8.4.1       Overview

8.4.2       Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.5       Epilepsy

8.5.1       Overview

8.5.2       Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.6       Tremor

8.6.1       Overview

8.6.2       Tremor: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

8.7       Incontinence

8.7.1       Overview

8.7.2       Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.8       Depression

8.8.1       Overview

8.8.2       Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.9       Dystonia

8.9.1       Overview

8.9.2       Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.10    Gastroparesis

8.10.1    Overview

8.10.2    Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.11    Parkinson’s Disease

8.11.1    Overview

8.11.2    Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.12    Obsessive-Compulsive Disorder (OCD)

8.12.1    Overview

8.12.2    Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

8.13    Migraine

8.13.1    Overview

8.13.2    Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.             Neuromodulation Market Analysis – By End User

9.1       Overview

9.2       Neuromodulation Market Share, by End User, 2019 and 2027, (%)

9.3       Hospitals

9.3.1       Overview

9.3.2       Hospitals: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.4       Clinics

9.4.1       Overview

9.4.2       Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

9.5       Home Healthcare

9.5.1       Overview

9.5.2       Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

10.          Neuromodulation Market Analysis and Forecasts To 2027 – Geographical Analysis

10.1    North America: Neuromodulation Market

10.1.1    Overview

10.1.2    North America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

10.1.3    North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.3.1    North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.1.3.2    North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4    North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.5    North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.6    North America: Neuromodulation Market, by Country, 2019 & 2027 (%)

10.1.7    US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.7.2.1    US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.2.2    US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3    US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.7.4    US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.8    Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.8.2.1    Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.1.8.2.2    Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.3    Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8.4    Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9    Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.1.9.2.1    Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.1.9.2.2    Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3    Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9.4    Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2    Europe: Neuromodulation Market

10.2.1    Overview

10.2.2    Europe: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

10.2.3    Europe: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.2.3.1    Europe: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.3.2    Europe: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.4    Europe: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.5    Europe: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.6    Europe: Neuromodulation Market, by Country, 2019 & 2027 (%)

10.2.7    Germany: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1    Germany: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2    Germany: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.2.7.2.1    Germany: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.2.7.2.2    Germany: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.3    Germany: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.7.4    Germany: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.8    UK: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1    UK: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2    UK: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.2.8.2.1    UK: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.2.2            UK: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.3    UK: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.8.4    UK: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.9    France: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1    France: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2    France: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.2.9.2.1    France: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.2.2    France: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.3    France: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.9.4    France: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.10 Spain: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Spain: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Spain: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.2.10.2.1 Spain: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.2.2 Spain: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.3 Spain: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.10.4 Spain: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.11 Italy: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1 Italy: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2 Italy: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.2.11.2.1 Italy: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.2.2 Italy: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.3 Italy: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.11.4 Italy: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3    Asia Pacific: Neuromodulation Market

10.3.1    Overview

10.3.2    Asia Pacific: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

10.3.3    Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.3.3.1    Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.3.3.2    Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.4    Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.5    Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.6    Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)

10.3.7    China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.1    China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.7.2    China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.3.7.2.1    China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.7.2.2    China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.7.3    China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.7.4    China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.8    Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.1    Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.8.2    Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.3.8.2.1    Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.8.2.2    Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.8.3    Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.8.4    Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.9    India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.1    India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.9.2    India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.3.9.2.1    India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.9.2.2    India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.9.3    India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.9.4    India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.10 South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1 South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.3.10.2.1 South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.3.10.2.2 South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.10.3 South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.10.4 South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.11 Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1 Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2 Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.3.11.2.1 Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.3.11.2.2 Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.11.3 Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.11.4 Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4    Middle East and Africa: Neuromodulation Market

10.4.1    Overview

10.4.2    Middle East and Africa: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

10.4.3    Middle East and Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027  (USD Million)

10.4.3.1    Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.3.2    Middle East and Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.4    Middle East and Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027  (USD Million)

10.4.5    Middle East and Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027  (USD Million)

10.4.6    Middle East and Africa: Neuromodulation Market, by Country, 2019 & 2027 (%)

10.4.7    Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.1    Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.2    Saudi Arabia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.4.7.2.1    Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.4.7.2.2    Saudi Arabia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.7.3    Saudi Arabia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.4.7.4    Saudi Arabia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4.8    UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.1    UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.2    UAE: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.4.8.2.1    UAE: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.2.2    UAE: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.3    UAE: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.4.8.4    UAE: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4.9    South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.1    South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.4.9.2    South Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.4.9.2.1    South Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.4.9.2.2    South Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.9.3    South Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.4.9.4    South Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5    South and Central America: Neuromodulation Market

10.5.1    Overview

10.5.2    South and Central America: Neuromodulation Market, - Revenue and Forecast to 2027 (USD Million)

10.5.3    South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.5.3.1    South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.3.2    South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.5.4    South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.5.5    South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027  (USD Million)

10.5.6    South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)

10.5.7    Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1    Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.2    Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.5.7.2.1    Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.2.2    Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.3    Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.5.7.4    Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5.8    Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.1    Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.2    Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

10.5.8.2.1    Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.5.8.2.2    Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.3    Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.5.8.4    Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.          Impact of COVID-19 Pandemic on Global Neuromodulation Market

11.1    North America: Impact Assessment of COVID-19 Pandemic

11.2    Europe: Impact Assessment of COVID-19 Pandemic

11.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

11.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

12.          Neuromodulation Market – Industry Landscape

12.1    Overview

12.2    Growth Strategies Done by the Companies in the Market, (%)

12.3    Organic Developments

12.3.1    Overview

12.4    Inorganic Developments

12.4.1    Overview

13.          Company Profiles

13.1    Abbott

13.1.1    Key Facts

13.1.2    Business Description

13.1.3    Products and Services

13.1.4    Financial Overview

13.1.5    SWOT Analysis

13.1.6    Key Developments

13.2    Boston Scientific Corporation

13.2.1    Key Facts

13.2.2    Business Description

13.2.3    Products and Services

13.2.4    Financial Overview

13.2.5    SWOT Analysis

13.2.6    Key Developments

13.3    Medtronic

13.3.1    Key Facts

13.3.2    Business Description

13.3.3    Products and Services

13.3.4    Financial Overview

13.3.5    SWOT Analysis

13.3.6    Key Developments

13.4    NeuroPace, Inc.

13.4.1    Key Facts

13.4.2    Business Description

13.4.3    Products and Services

13.4.4    Financial Overview

13.4.5    SWOT Analysis

13.4.6    Key Developments

13.5    NeuroSigma, Inc.

13.5.1    Key Facts

13.5.2    Business Description

13.5.3    Products and Services

13.5.4    Financial Overview

13.5.5    SWOT Analysis

13.5.6    Key Developments

13.6    NEVRO CORP.

13.6.1    Key Facts

13.6.2    Business Description

13.6.3    Products and Services

13.6.4    Financial Overview

13.6.5    SWOT Analysis

13.6.6    Key Developments

13.7    Synapse Biomedical Inc.

13.7.1    Key Facts

13.7.2    Business Description

13.7.3    Products and Services

13.7.4    Financial Overview

13.7.5    SWOT Analysis

13.7.6    Key Developments

13.8    Soterix Medical Inc

13.8.1    Key Facts

13.8.2    Business Description

13.8.3    Products and Services

13.8.4    Financial Overview

13.8.5    SWOT Analysis

13.8.6    Key Developments

13.9    Integer Holdings Corporation

13.9.1    Key Facts

13.9.2    Business Description

13.9.3    Products and Services

13.9.4    Financial Overview

13.9.5    SWOT Analysis

13.9.6    Key Developments

13.10  Magstim

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14.          Appendix

14.1    Glossary of Terms


 

LIST OF TABLES

Table 1.             North America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 2.             North America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             North America: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 6.             US: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 7.             US: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             US: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             US: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 10.          US: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 13.          Canada: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 17.          Mexico: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 18.          Mexico: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 21.          Europe: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 22.          Europe: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 23.          Europe: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          Europe: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 25.          Europe: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 26.          Germany: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 27.          Germany: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 28.          Germany: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 29.          Germany: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 30.          Germany: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31.          UK: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 32.          UK: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 33.          UK: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 34.          UK: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 35.          UK: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 36.          France: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 37.          France: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 38.          France: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 39.          France: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 40.          France: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 41.          Spain: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 42.          Spain: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 43.          Spain: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 44.          Spain: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 45.          Spain: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 46.          Italy: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 47.          Italy: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 48.          Italy: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 49.          Italy: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 50.          Italy: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 51.          Asia Pacific: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 52.          Asia Pacific: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 53.          Asia Pacific: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 54.          Asia Pacific: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 55.          Asia Pacific: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 56.          China: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 57.          China: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 58.          China: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 59.          China: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 60.          China: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 61.          Japan: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 62.          Japan: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 63.          Japan: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 64.          Japan: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 65.          Japan: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 66.          India: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 67.          India: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 68.          India: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 69.          India: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 70.          India: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 71.          South Korea: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 72.          South Korea: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 73.          South Korea: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 74.          South Korea: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 75.          South Korea: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 76.          Australia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 77.          Australia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 78.          Australia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 79.          Australia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 80.          Australia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 81.          Middle East and Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 82.          Middle East and Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 83.          Middle East and Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 84.          Middle East and Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 85.          Middle East and Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 86.          Saudi Arabia: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 87.          Saudi Arabia: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 88.          Saudi Arabia: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 89.          Saudi Arabia: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 90.          Saudi Arabia: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 91.          UAE: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 92.          UAE: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 93.          UAE: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 94.          UAE: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 95.          UAE: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 96.          South Africa: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 97.          South Africa: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 98.          South Africa: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 99.          South Africa: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 100.       South Africa: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 101.       South and Central America: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 102.       South and Central America: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 103.       South and Central America: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 104.       South and Central America: Neuromodulation Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 105.       South and Central America: Neuromodulation Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 106.       Brazil: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 107.       Brazil: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 108.       Brazil: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 109.       Brazil: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 110.       Brazil: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 111.       Argentina: Neuromodulation Market, by Technology – Revenue and Forecast to 2027 (USD Million)

Table 112.       Argentina: External (Non-Invasive) Neuromodulation Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 113.       Argentina: Internal Neuromodulation Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 114.       Argentina: Neuromodulation Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 115.       Argentina: Neuromodulation Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 116.       Organic Developments Done by Companies

Table 117.       Inorganic Developments Done by Companies

Table 118.       Glossary of Terms, Neuromodulation Market

 


LIST OF FIGURES

Figure 1.           Neuromodulation Market Segmentation

Figure 2.           Neuromodulation Market – By Geography

Figure 3.           Global Neuromodulation Market Overview

Figure 4.           Internal Neuromodulation Segment Held Largest Share of Product Type Segment in Neuromodulation Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Neuromodulation Market, By Geography (US$ Million)

Figure 7.           Global Neuromodulation Market- Leading Country Markets (US$ Million)

Figure 8.           Global Neuromodulation Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East and Africa (MEA) PEST Analysis

Figure 13.        South and Central America (SCAM) PEST Analysis

Figure 14.        Neuromodulation Market Impact Analysis of Drivers and Restraint

Figure 15.        Global Neuromodulation Market– Revenue Forecast and Analysis – 2019- 2027

Figure 16.        Global Neuromodulation Market– By Geography Forecast and Analysis – 2019- 2027

Figure 17.        Market Positioning of Key Players in Global Neuromodulation Market

Figure 18.        Neuromodulation Market Share, by Technology, 2019 and 2027 (%)

Figure 19.        External Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Respiratory Electrical Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Transcutaneous Electrical Nerve Stimulation (TENS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Transcranial Magnetic Stimulation (TMS): Neuromodulation Market– Revenue and Forecast to 2027  (US$ Million)

Figure 23.        Internal Neuromodulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Deep Brain Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Sacral Nerve Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Gastric Electric Stimulation: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Spinal Cord Stimulation (SCS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Vagus Nerve Stimulation (VNS): Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Neuromodulation Market Share, by Application, 2019 and 2027 (%)

Figure 30.        Chronic Pain Management: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 31.        Failed Back Syndrome: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 32.        Epilepsy: Neuromodulation Market– Revenue and Forecast to 2027 (US$ Million)

Figure 33.        Tremor: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        Incontinence: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Depression: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        Dystonia: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 37.        Gastroparesis: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 38.        Parkinson’s Disease: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 39.        Obsessive-Compulsive Disorder: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 40.        Migraine: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 41.        Neuromodulation Market Share, by End User, 2019 and 2027 (%)

Figure 42.        Hospitals Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 43.        Clinics: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 44.        Home Healthcare: Neuromodulation Market – Revenue and Forecast to 2027 (US$ Million)

Figure 45.        North America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 46.        North America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 47.        North America: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 48.        US: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        Canada: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        Mexico: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 51.        Europe: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 52.        Europe: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 53.        Europe: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 54.        Germany: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        UK: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 56.        France: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Spain: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 58.        Italy: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 59.        Asia Pacific: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 60.        Asia Pacific: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 61.        Asia Pacific: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 62.        China: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 63.        Japan: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 64.        India: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 65.        South Korea: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 66.        Australia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 67.        Middle East and Africa: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 68.        Middle East and Africa: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 69.        Middle East and Africa: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 70.        Saudi Arabia: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 71.        UAE: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 72.        South Africa: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 73.        South and Central America: Neuromodulation Market, by Key Country – Revenue (2019) (USD Million)

Figure 74.        South and Central America: Neuromodulation Market, Revenue and Forecast to 2027 (USD Million)

Figure 75.        South and Central America: Neuromodulation Market, by Country, 2019 & 2027 (%)

Figure 76.        Brazil: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 77.        Argentina: Neuromodulation Market – Revenue and Forecast to 2027 (USD Million)

Figure 78.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 79.        Impact of COVID-19 Pandemic in European Country Markets

Figure 80.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 81.        Impact of COVID-19 Pandemic in Rest of the World Country Market

Figure 82.        Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - Neuromodulation Market

  1. Abbott
  2. Boston Scientific Corporation
  3. Medtronic
  4. NeuroPace, Inc.
  5. NeuroSigma, Inc.
  6. NEVRO CORP.
  7. Synapse Biomedical Inc.
  8. Soterix Medical Inc
  9. Integer Holdings Corporation
  10. Magstim
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the neuromodulation market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global neuromodulation market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPHE100001415
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.

The global neuromodulation market is being driven by factors such as increasing incidence of neurological disorders, growing developments in neuromodulation technology. Furthermore, rising demand for neurostimulation devices to treat chronic pain is likely to offer significant opportunities for the growth of the global neurostimulation market.

The high cost of neuromodulation devices is the significant factor that will hinder the neuromodulation market growth.

Pricing
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2020 - The Insight Partners. All rights reserved